Located just outside WASHINGTON DC
, The Degge Group
provides consulting services to the biopharmaceutical and medical
products sector specializing in clinical drug safety,
pharmacovigilance, medical product epidemiology, and risk management.
Degge's staff has contributed to the burgeoning fields of
pharmacoepidemiology and pharmacovigilance for over two decades and
has worked to enhance the understanding of drug safety, drug use,
natural history of disease studies, risk evaluation and mitigation
strategies (REMS), benefit-risk assessments, and pharmacoeconomic and
Degge will help you identify and analyze key data to meet your needs.
Dr. Anokhi Kapasi, Molecular Epidemiologist at The Degge Group, has been recognized as an exceptional peer reviewer
by the editors of the journal Pharmacoepidemiology and Drug Safety
(August 2015). Degge congratulates her on this achievement.
Degge's President, Dr. Judith K. Jones, delivered one of 3 keynote
- The Next Thirty Years: From where have we come, and where are we
going in the next 30 years.
" at this year's 30th
International Conference on Pharmacoepidemiology & Therapeutic
Risk Management (ICPE
in Taipei, Taiwan
(October 24 - 27, 2014). More Degge News